Back
Kymera Therapeutics, Inc. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Buy
72
KYMR
Kymera Therapeutics, Inc.
Last Price:
$94.38
Seasonality Move:
7.7%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Kymera Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.47 | Buy |
| 20-day SMA: | 64.83 | Buy |
| 50-day SMA: | 61.21 | Buy |
| 200-day SMA: | 43.96 | Buy |
| 8-day EMA: | 66.09 | Buy |
| 20-day EMA: | 64.75 | Buy |
| 50-day EMA: | 60.61 | Buy |
| 200-day EMA: | 48.97 | Buy |
Kymera Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.78 | Buy |
| Relative Strength Index (14 RSI): | 60.29 | Buy |
| Chaikin Money Flow: | 254539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.36 - 66.56) | Buy |
| Bollinger Bands (100): | (43.77 - 61.91) | Buy |
Kymera Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics, Inc. Stock
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 66.62 while KYMR 8-day simple moving average is 66.47, which is a Buy signal.
-
The stock price of KYMR is 66.62 while Kymera Therapeutics, Inc. 20-day SMA is 64.83, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day simple moving average is 61.21 while KYMR share price is 66.62, making it a Buy technically.
-
KYMR stock price is 66.62 and Kymera Therapeutics, Inc. 200-day simple moving average is 43.96, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
72
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy or a Sell?
-
Kymera Therapeutics, Inc. stock is rated a BuyThe current Kymera Therapeutics, Inc. [KYMR] share price is $66.62. The Score for KYMR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics, Inc. Stock Info
Market Cap:
6.8B
Price in USD:
66.62
Share Volume:
392.7K
Kymera Therapeutics, Inc. 52-Week Range
52-Week High:
68.80
52-Week Low:
19.45
Buy
72
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Kymera Therapeutics, Inc. Share Price Forecast
-
What is the Kymera Therapeutics, Inc. stock price today?The Kymera Therapeutics, Inc. stock price is 66.62 USD today.
-
Will KYMR stock go up or go down?Kymera Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Kymera Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics, Inc. is not overvalued.
Is Kymera Therapeutics, Inc. Stock a Buy?
-
Kymera Therapeutics, Inc. share price is 66.62 while KYMR 8-day exponential moving average is 66.09, which is a Buy signal.
-
The stock price of KYMR is 66.62 while Kymera Therapeutics, Inc. 20-day EMA is 64.75, which makes it a Buy.
-
Kymera Therapeutics, Inc. 50-day exponential moving average is 60.61 while KYMR share price is 66.62, making it a Buy technically.
-
KYMR stock price is 66.62 and Kymera Therapeutics, Inc. 200-day simple moving average is 48.97, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics, Inc.
Is Kymera Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Kymera Therapeutics, Inc.
Should I short Kymera Therapeutics, Inc. stock?
-
KYMR Moving Average Covergence Divergence (MACD) indicator is 1.78, suggesting Kymera Therapeutics, Inc. is a Buy
-
Kymera Therapeutics, Inc. Relative Strength Index (RSI) is 60.29, which suggest Kymera Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Kymera Therapeutics, Inc. is (61.36 - 66.56), which suggest Kymera Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Kymera Therapeutics, Inc. is (43.77 - 61.91), which suggest Kymera Therapeutics, Inc. is a Buy
* Kymera Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.